Tackling Global Health Issues Through Law and Policy

American Journal of Law and Medicine Annual Symposium

Feb. 2, 2008

Our upcoming symposium deals with obstacles to creating medicines for the developing world.  The American Journal of Law and Medicine will publish the papers presented at this working conference in a special issue (Vol. 34: Nos. 2 & 3, forthcoming in June of 2008).  This symposium brings together a broad spectrum of scholars and key stakeholders from the legal, medical, and economic fields to address what is today one of the most pressing issues confronting the world.  A wide range of topics will be discussed, including: how the law can be used to combat diseases in developing nations (including the AIDS epidemic), the role of international organizations in promoting public health, and legal and policy issues for the global pharmaceutical industry.  This symposium will educate our readers about various aspects of this critical problem, and will promote the importance of global health consciousness across professions.

  • Erik Iverson, Introduction
  • Brook K. Baker, Ending Drug Registration Apartheid: Taming Data Exclusivity And Patent/Registration Linkage
  • Peter Drahos, “Trust Me”: Patent Offices In Developing Countries
  • Graham Dutfield, Delivering Drugs To The Poor: Will The TRIPS Amendment Help?
  • Gail E. Evans, Strategic Patent Licensing For Public Research Organizations: Deploying Restriction And Reservation Clauses To Promote Medical R&D In Developing Countries
  • Aaron S. Kesselheim, Think Globally, Prescribe Locally: How Rational Pharmaceutical Policy In The U.S. Can Improve Global Access To Essential Medicines
  • Gerald T. Keusch, When You Reach A Fork In The Road, Take It: Science And Product Development As Linked Paths
  • Jack Lerner, Intergovernmental Organizations, Intellectual Property, And Access To Medicine In Developing Countries
  • Ruth Levine, Demand Forecasting For Essential Medical Technologies
  • Kevin Outterson, Should Access to Medicines And TRIPS Flexibilities Be Limited To Specific Diseases?
  • Peter K. Yu, Access to Medicines, BRICS Alliances, And Collective Action

Speakers: Selected Bibliography

Researching International and National Intellectual Property Law and Public Health

 

Page maintained by Stefanie Weigmann
Last updated: January 2008